Aman Chauhan: I’m honored to have the opportunity to speak at Gilda’s Club
Aman Chauhan shared on X/Twitter:
“I’m honored to have the opportunity to speak at Gilda’s Club about rare and aggressive neuroendocrine carcinoma. This critical issue demands our attention and action. Please join us in supporting this vital cause.
Gilda’s Club South Florida’s 22nd Annual Research and Hope Educational Conference.
Visit here to view the schedule and reserve your ticket for this FREE conference!
FREE 3.0 continuing education credits will be provided to nurses and mental health professionals after the conference.”
Source: Aman Chauhan/X
Dr. Aman Chauhan leads the University of Miami Neuroendocrine Cancer Program and focuses on treating neuroendocrine tumors (NETs), including carcinoid tumors and high-grade neuroendocrine carcinomas.
He is the national principal investigator for several investigator-initiated neuroendocrine cancer theranostics clinical trials. Dr. Chauhan serves on AJCC and ASCO NET guideline committees, and is an active member of the NANETS communication committee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023